Cargando…

Congenital Nasolacrimal Duct Obstruction and Refractive Amblyopia Risk Factors: Effect of Age at the Time of Probing

OBJECTIVES: To determine whether treatment time of congenital nasolacrimal duct obstruction (CNLDO) has any effect on refractive amblyopia risk factors (ARFs). METHODS: This is a cross-sectional study and it was conducted in the Pediatric Ophthalmology Department at Kayseri City Training and Researc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilic, Deniz, Aydin, Ismail, Sirem, Muhammed Rasit, Birgin, Hatice, Guven, Soner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874263/
https://www.ncbi.nlm.nih.gov/pubmed/35265799
http://dx.doi.org/10.14744/bej.2021.30974
_version_ 1784657643598512128
author Kilic, Deniz
Aydin, Ismail
Sirem, Muhammed Rasit
Birgin, Hatice
Guven, Soner
author_facet Kilic, Deniz
Aydin, Ismail
Sirem, Muhammed Rasit
Birgin, Hatice
Guven, Soner
author_sort Kilic, Deniz
collection PubMed
description OBJECTIVES: To determine whether treatment time of congenital nasolacrimal duct obstruction (CNLDO) has any effect on refractive amblyopia risk factors (ARFs). METHODS: This is a cross-sectional study and it was conducted in the Pediatric Ophthalmology Department at Kayseri City Training and Research Hospital. The ages of 174 patients who underwent probing were obtained from electronic medical charts and used to divide the patients into two groups: an early-probing group (<24 months old) and a late-probing group (≥24 months old). After inclusion criteria were applied, a pediatric ophthalmologist examined 189 eyes of the 174 patients. The groups were evaluated and compared for cycloplegic refractive errors. RESULTS: The median age of patients who underwent probing was 30 months (ranging from 11–44 months). A total of 40 of 189 eyes (21.2%) examined had refractive ARFs, which were significantly more prevalent in the late-probing group (p=0.044). The ARFs associated with astigmatism were greater in the late- versus the early-probing group (p=0.037), whereas no other refractive ARFs or anisometropia differed between the groups (p=0.887 for myopia, p=0.364 for hyperopia, and p=0.672 for anisometropia). Astigmatic ARFs were significantly higher in the late-treatment group. CONCLUSION: Astigmatic ARFs were significantly higher in the late-treatment group. Therefore, ophthalmologists should regularly monitor the refractive status of children with CNLDO, especially those treated after 24 months old.
format Online
Article
Text
id pubmed-8874263
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-88742632022-03-08 Congenital Nasolacrimal Duct Obstruction and Refractive Amblyopia Risk Factors: Effect of Age at the Time of Probing Kilic, Deniz Aydin, Ismail Sirem, Muhammed Rasit Birgin, Hatice Guven, Soner Beyoglu Eye J Original Article OBJECTIVES: To determine whether treatment time of congenital nasolacrimal duct obstruction (CNLDO) has any effect on refractive amblyopia risk factors (ARFs). METHODS: This is a cross-sectional study and it was conducted in the Pediatric Ophthalmology Department at Kayseri City Training and Research Hospital. The ages of 174 patients who underwent probing were obtained from electronic medical charts and used to divide the patients into two groups: an early-probing group (<24 months old) and a late-probing group (≥24 months old). After inclusion criteria were applied, a pediatric ophthalmologist examined 189 eyes of the 174 patients. The groups were evaluated and compared for cycloplegic refractive errors. RESULTS: The median age of patients who underwent probing was 30 months (ranging from 11–44 months). A total of 40 of 189 eyes (21.2%) examined had refractive ARFs, which were significantly more prevalent in the late-probing group (p=0.044). The ARFs associated with astigmatism were greater in the late- versus the early-probing group (p=0.037), whereas no other refractive ARFs or anisometropia differed between the groups (p=0.887 for myopia, p=0.364 for hyperopia, and p=0.672 for anisometropia). Astigmatic ARFs were significantly higher in the late-treatment group. CONCLUSION: Astigmatic ARFs were significantly higher in the late-treatment group. Therefore, ophthalmologists should regularly monitor the refractive status of children with CNLDO, especially those treated after 24 months old. Kare Publishing 2022-02-18 /pmc/articles/PMC8874263/ /pubmed/35265799 http://dx.doi.org/10.14744/bej.2021.30974 Text en Copyright: © 2022 by Beyoglu Eye Training and Research Hospital https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Original Article
Kilic, Deniz
Aydin, Ismail
Sirem, Muhammed Rasit
Birgin, Hatice
Guven, Soner
Congenital Nasolacrimal Duct Obstruction and Refractive Amblyopia Risk Factors: Effect of Age at the Time of Probing
title Congenital Nasolacrimal Duct Obstruction and Refractive Amblyopia Risk Factors: Effect of Age at the Time of Probing
title_full Congenital Nasolacrimal Duct Obstruction and Refractive Amblyopia Risk Factors: Effect of Age at the Time of Probing
title_fullStr Congenital Nasolacrimal Duct Obstruction and Refractive Amblyopia Risk Factors: Effect of Age at the Time of Probing
title_full_unstemmed Congenital Nasolacrimal Duct Obstruction and Refractive Amblyopia Risk Factors: Effect of Age at the Time of Probing
title_short Congenital Nasolacrimal Duct Obstruction and Refractive Amblyopia Risk Factors: Effect of Age at the Time of Probing
title_sort congenital nasolacrimal duct obstruction and refractive amblyopia risk factors: effect of age at the time of probing
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874263/
https://www.ncbi.nlm.nih.gov/pubmed/35265799
http://dx.doi.org/10.14744/bej.2021.30974
work_keys_str_mv AT kilicdeniz congenitalnasolacrimalductobstructionandrefractiveamblyopiariskfactorseffectofageatthetimeofprobing
AT aydinismail congenitalnasolacrimalductobstructionandrefractiveamblyopiariskfactorseffectofageatthetimeofprobing
AT siremmuhammedrasit congenitalnasolacrimalductobstructionandrefractiveamblyopiariskfactorseffectofageatthetimeofprobing
AT birginhatice congenitalnasolacrimalductobstructionandrefractiveamblyopiariskfactorseffectofageatthetimeofprobing
AT guvensoner congenitalnasolacrimalductobstructionandrefractiveamblyopiariskfactorseffectofageatthetimeofprobing